X

Other Industries

Mylan under pressure as shortage of anti-allergy injector persists

Pharmaceutical company Mylan (Nasdaq: MYL), which has been facing criticism for the short supply of its anti-allergy injector EpiPen, suffered…

Virgin Galactic vs. Blue Origin: The race to suborbital space tourism

Written by Arjun Vijay On Tuesday, Virgin Galactic announced that it was going public, setting a new milestone for the…

AngioDynamics posts in-line EPS of $0.25 in Q4

AngioDynamics (NASDAQ: ANGO) posted fourth-quarter earnings results on Wednesday before the regular trading hours. Net sales for the period increased 9%…

Levi Strauss stock falls after Q2 earnings drop on IPO costs, miss estimates

Denim specialist Levi Strauss (NYSE: LEVI), which returned to the public market two months ago, reported weaker than expected earnings…

Cronos Group ropes in Mondelez executive to drive innovation in product development

Global cannabinoid firm, Cronos Group (NASDAQ: CRON) on Tuesday announced the appointment of Dr. Todd Abraham as its Chief Innovation…

Lindsay Q3 profit dips 72%, misses estimates

Lindsay Corporation (NYSE: LNN) reported a 72% dip in earnings for the third quarter of fiscal 2019 due to lower…

What to expect from PriceSmart Q3 2019 earnings?

PriceSmart Inc. (NASDAQ: PSMT) is scheduled to report its earnings results for the third quarter of 2019 on Wednesday after…

Earnings preview: Here’s what to look for in Fastenal’s Q2 report

Fastenal Company (Nasdaq: FAST) will be reporting second-quarter results Thursday before the opening bell. The market’s prediction of $0.37 per…

AZZ Q1 profit beats estimates, reaffirms FY20 forecast

AZZ Inc. (NYSE: AZZ) reported a 35% jump in earnings for the first quarter of fiscal 2020 helped by solid…

Earnings preview: Trade concerns to hurt Lindsay Q3 2019 results

Lindsay Corporation (NYSE: LNN) continued to face the wrath of the trade concerns, which weigh on farmer sentiment and impacting…